FAM225B Is a Prognostic lncRNA for Patients with Recurrent Glioblastoma
Objective. The overall survival of patients with recurrent glioblastoma (rGBM) is quite different, so clinical outcome prediction is necessary to guide personalized clinical treatment for patients with rGBM. The expression level of lncRNA FAM225B was analyzed to determine its prognostic value in rGB...
Main Authors: | Junsheng Li, Qian Zhang, Peicong Ge, Chaofan Zeng, Fa Lin, Wen Wang, Jizong Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2020/8888085 |
Similar Items
-
The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis
by: Qin Yang, et al.
Published: (2020-03-01) -
A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
by: Xiaomeng Li, et al.
Published: (2021-02-01) -
LncRNA GAS8‐AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation
by: Xiaoming Wu, et al.
Published: (2021-06-01) -
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
by: Yang F, et al.
Published: (2016-11-01) -
Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles
by: Qinglin Liu, et al.
Published: (2019-01-01)